Trial NCT01430585

View at ClinicalTrials.gov 
Org. Study IDs: B1271003

Last trial update was posted on 2014-08-12

MeSH Interventions

Letrozole

MeSH Conditions

Breast Neoplasms

Other Conditions

Advanced Breast Cancer (Phase 1b) Early Breast Cancer (Phase 2)

Stopping Reasons

See termination reason in detailed description.

Limitations And Caveats

Study was prematurely terminated due to PF-04691502 tolerability findings that prompted Sponsor to re-evaluate strategic goals of program. Unexpected frequency of severe skin toxicity was observed and no participant was enrolled in phase 2 of study.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID